#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5043200	A	Drugmetabolism in mouse liver microsomes assessed as metabolite formation	Mus musculus	1	ALA5042486	microsome format	Scientific Literature
2.	ALA5043201	F	Inhibition of FcgammaRIII mediated TNF alpha secretion in cross-linked anti-CD16 stimulated human monocyte	Homo sapiens	1	ALA5042486	cell-based format	Scientific Literature
3.	ALA5043203	B	Inhibition of human BTK using fluorescein-labeled polyGAT peptide as substrate incubated for 30 mins by FRET assay	Homo sapiens	40	ALA5042486	single protein format	Scientific Literature
4.	ALA5043204	B	Inhibition of BTK phosphorylation in human whole blood assessed as reduction in BTK phosphorylation incubated for 30 mins	Homo sapiens	17	ALA5042486	tissue-based format	Scientific Literature
5.	ALA5043205	B	Inhibition of CD69 in human whole blood preincubated for 30 mins followed by anti-human IgD stimulation and measured after 18 to 22 hrs by flow cytometry	Homo sapiens	27	ALA5042486	tissue-based format	Scientific Literature
6.	ALA5043206	P	Kinetic aqueous solubility of the compound in pH 6.8		16	ALA5042486	small-molecule physicochemical format	Scientific Literature
7.	ALA5043208	A	Clearance in rat liver microsomes assessed as hepatic blood flow	Rattus norvegicus	13	ALA5042486	microsome format	Scientific Literature
8.	ALA5043209	A	Clearance in human liver microsomes assessed as hepatic blood flow	Homo sapiens	13	ALA5042486	microsome format	Scientific Literature
9.	ALA5043210	A	Protein binding in human plasma assessed as unbound fraction at 2 uM by rapid equilibrium dialysis method	Homo sapiens	13	ALA5042486	cell-free format	Scientific Literature
10.	ALA5043211	P	Kinetic solubility of the compound at pH 1.5 by shake flask method		13	ALA5042486	small-molecule physicochemical format	Scientific Literature
11.	ALA5043213	P	Lipophilicity, logD of the compound at pH 7.6 by shake flask assay		13	ALA5042486	small-molecule physicochemical format	Scientific Literature
12.	ALA5043215	A	Clearance in Sprague-Dawley rat at 1 mg/kg, iv	Rattus norvegicus	3	ALA5042486	organism-based format	Scientific Literature
13.	ALA5043216	A	Clearance in Beagle dog at 1 mg/kg, iv	Canis lupus familiaris	3	ALA5042486	organism-based format	Scientific Literature
14.	ALA5043217	A	Clearance in Sprague-Dawley rat assessed as hepatic blood flow at 1 mg/kg, iv	Rattus norvegicus	3	ALA5042486	organism-based format	Scientific Literature
15.	ALA5043218	A	Clearance in Beagle dog assessed as hepatic blood flow at 1 mg/kg, iv	Canis lupus familiaris	3	ALA5042486	organism-based format	Scientific Literature
16.	ALA5043224	A	Cmax in Sprague-Dawley rat at 5 mg/kg, po	Rattus norvegicus	3	ALA5042486	organism-based format	Scientific Literature
17.	ALA5043225	A	Cmax in Beagle dog at 5 mg/kg, po	Canis lupus familiaris	3	ALA5042486	organism-based format	Scientific Literature
18.	ALA5043226	A	Oral bioavailability in Sprague-Dawley rat at 5 mg/kg	Rattus norvegicus	3	ALA5042486	organism-based format	Scientific Literature
19.	ALA5043227	A	Oral bioavailability in Beagle dog at 5 mg/kg	Canis lupus familiaris	3	ALA5042486	organism-based format	Scientific Literature
20.	ALA5043231	B	Binding affinity to wild-type human full length BTK (M1 to S659 residues) expressed in mammalian expression system by Kinomescan method	Homo sapiens	4	ALA5042486	assay format	Scientific Literature